I farmaci oncologici noti anche come farmaci antitumorali o farmaci antineoplastici, i farmaci antitumorali sono agenti che possono essere utilizzati da soli o in combinazione per controllare o distruggere le cellule cancerose. Esistono molti tipi diversi di farmaci antitumorali disponibili sul mercato. Alcuni curano il cancro e altri aiutano ad alleviare sintomi come nausea e dolore. Il tipo di farmaci prescritti al paziente dipende dal tipo di cancro che il paziente ha. Alcuni farmaci antitumorali possono essere assunti sotto forma di compresse, supposte o cerotti. I farmaci antitumorali come la chemioterapia vengono solitamente somministrati in cicli nell'arco di diversi mesi.
DINAMICHE DEL MERCATO
In aumento varie condizioni di cancro, crescenti progressi nelle terapie (farmaci biologici e mirati terapie) e l’aumento della popolazione geriatrica sono i principali fattori che guidano la crescita del mercato globale dei farmaci antitumorali. La consapevolezza sui farmaci antitumorali e sulla loro disponibilità stimola ulteriormente la crescita del mercato. Anche l’aumento del numero di farmaci antitumorali in cantiere e l’aumento della domanda portano a nuove opportunità per gli operatori del mercato. Mentre l'elevato costo dei farmaci e l'azione inversa associata ai farmaci antitumorali impediscono la crescita del mercato.
AMBITO DI MERCATO
L'analisi del mercato globale dei farmaci antitumorali fino al 2031 " è uno studio specializzato e approfondito con particolare attenzione all'analisi delle tendenze del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato dei farmaci antitumorali con una segmentazione dettagliata del mercato per tipo di farmaco, tipo di terapia, tipo di cancro e area geografica. Si prevede che il mercato globale dei farmaci antitumorali assisterà a una crescita elevata durante il periodo di previsione. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori del mercato farmaci antitumorali e offre tendenze e opportunità chiave nel mercato.
SEGMENTAZIONE DEL MERCATO
L’antitumorale globale Il mercato dei farmaci è segmentato in base al tipo di farmaco, al tipo di terapia e al tipo di cancro. In base al tipo di farmaco, il mercato è segmentato in farmaci citotossici, farmaci mirati e farmaci ormonali. In base al tipo di terapia i segmenti vengono classificati come chemioterapia, terapia mirata e immunoterapia. Sulla base del tipo di cancro, la segmentazione del mercato è classificata come cancro ai polmoni, cancro al seno, leucemia e cancro del colon-retto.
Il rapporto fornisce un panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del mercato globale dei farmaci antitumorali in base a vari segmenti. Fornisce inoltre stime sulle dimensioni del mercato e sulle previsioni dall'anno 2021 al 2031 rispetto a cinque regioni principali, vale a dire; Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e Sud & America Centrale. Il mercato dei farmaci antitumorali per ciascuna regione viene successivamente suddiviso in sottosegmenti per rispettivi paesi e segmenti. Il rapporto copre l'analisi e le previsioni di 18 paesi a livello globale insieme alle tendenze attuali e alle opportunità prevalenti nella regione.
Il rapporto analizza i fattori che influenzano il mercato dei farmaci antitumorali sia dal lato della domanda che dell'offerta e valuta ulteriormente le dinamiche di mercato che incidono sul mercato dei farmaci antitumorali. mercato durante il periodo di previsione, ovvero fattori trainanti, restrizioni, opportunità e tendenza futura. Il rapporto fornisce anche un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e Sud & America Centrale dopo aver valutato i fattori politici, economici, sociali e tecnologici che influenzano il mercato dei farmaci antitumorali in queste regioni.
ATTORI DI MERCATO
Il i rapporti coprono gli sviluppi chiave nel mercato dei farmaci antitumorali come strategie di crescita organica e inorganica. Diverse aziende si stanno concentrando su strategie di crescita organica come lanci di prodotti, approvazioni di prodotti e altri come brevetti ed eventi. Le attività delle strategie di crescita inorganica testimoniate nel mercato sono state acquisizioni e partnership & collaborazioni. Queste attività hanno aperto la strada all’espansione del business e della base clienti degli operatori del mercato. Si prevede che gli operatori del mercato dei farmaci antitumorali avranno opportunità di crescita redditizie in futuro con la crescente domanda di farmaci antitumorali nel mercato globale. Di seguito è riportato l'elenco di alcune aziende impegnate nel mercato dei farmaci antitumorali.
Il rapporto include anche i profili delle principali società del mercato dei farmaci antitumorali insieme alle loro analisi SWOT e strategie di mercato. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni, sviluppi chiave negli ultimi cinque anni.
- AbbVie Inc.< /li>
- Astellas Pharma Inc.
- AstraZeneca PLC
- Celgene Corporation
- F. Hoffmann-la Roche ltd.
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. AbbVie Inc.
2. Astellas Pharma Inc.
3. AstraZeneca PLC
4. Celgene Corporation
5. F. Hoffmann-la Roche ltd.
6. Johnson & Johnson
7. Merck & Co., Inc.
8. Novartis AG
9. Pfizer Inc.
10. Sanofi
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For